Ellice Wong, MD
Assistant Professor of Medicine (Medical Oncology); Director, Newington VA Hematology/Oncology Service
Research & Publications
Biography
News
Coauthors
Selected Publications
- MDS ChapterWong EY, Rose MG. Update on MDS for Cancer: Principles & Practice of Oncology, 12th edition, 2023.
- CML ChapterWong EY, Rose MG. Update on CML for Cancer: Principles & Practice of Oncology, 12th edition, 2023.
- CLL ChapterWong EY, Rose MG. Update on CLL for Cancer: Principles & Practice of Oncology, 12th edition, 2023.
- Disorders of Red Blood CellsWong E, Rose MG, Berliner N. Disorders of red blood cells. In: Wing E. and Shiffman F. eds. Cesil Essentials of Medicine, 10th ed. Elsevier 2020.
- Clinical Disorders of Granulocytes and MonocytesWong E, Rose MG and Berliner N. Clinical Disorders of Granulocytes and Monocytes. In: Wing E. and Schiffman F. eds. Cecil Essentials of Medicine, 10th ed. Elsevier 2020.
- Multicenter phase II trial of RRx-001 in previously treated SCLC.Morgensztern D, Rose M, Morris J, Ma P, Brzezniak C, Zeman K, Padmanabhan A, Hirth J, Spira A, Wong E, Padda S, Waqar S. Multicenter phase II trial of RRx-001 in previously treated SCLC. Journal Of Clinical Oncology 2019, 37: e20104-e20104. DOI: 10.1200/jco.2019.37.15_suppl.e20104.
- Duffy Antigen Phenotyping Is a Useful and Clinically Available Test for Benign Ethnic NeutropeniaChang E, Tormey C, Siddon A, Rahmani M, Wong E. Duffy Antigen Phenotyping Is a Useful and Clinically Available Test for Benign Ethnic Neutropenia. Blood 2018, 132: 2546. DOI: 10.1182/blood-2018-99-117178.
- Impact of HIV on Clinical Presentation and Outcomes of Individuals with Multiple MyelomaGiri S, Wong E, Rose M, Wadia R, Park L, Justice A, Neparidze N. Impact of HIV on Clinical Presentation and Outcomes of Individuals with Multiple Myeloma. Blood 2018, 132: 3162. DOI: 10.1182/blood-2018-99-115633.
- Targeting Protein Disulfide Isomerase with the Oral Flavonoid Isoquercetin Prevents Venous Thromboembolism in Advanced Cancer: Results of a Multi-Dose, Multi-Center, Phase II Clinical Trial (CATIQ Study)Zwicker J, Schlechter B, Stopa J, Liebman H, Aggarwal A, Caughey T, Bauer K, Kuemmerle N, Wong E, Wun T, Mclaughlin M, Puligandla M, Neuberg D, Furie B, Flaumenhaft R. Targeting Protein Disulfide Isomerase with the Oral Flavonoid Isoquercetin Prevents Venous Thromboembolism in Advanced Cancer: Results of a Multi-Dose, Multi-Center, Phase II Clinical Trial (CATIQ Study). Blood 2018, 132: 985. DOI: 10.1182/blood-2018-99-114946.
- QUADRUPLE THREAT: A phase II trial of RRx-001 followed by etoposide-platinum re-challenge in previously treated small cell lung cancer.Padda S, Brzezniak C, Waqar S, Wakelee H, Ma P, Rose M, Reid T, Spira A, Wong E, Zeman K, Oronsky B, Abrouk N, Morgensztern D. QUADRUPLE THREAT: A phase II trial of RRx-001 followed by etoposide-platinum re-challenge in previously treated small cell lung cancer. Journal Of Clinical Oncology 2018, 36: e20575-e20575. DOI: 10.1200/jco.2018.36.15_suppl.e20575.
- Electronic Hematology Consultations at Veterans Affairs (VA) Connecticut: Analysis of Effects on Patient Care, and Provider and Patient SatisfactionNeparidze N, Cecchini M, Wong E, Rose M. Electronic Hematology Consultations at Veterans Affairs (VA) Connecticut: Analysis of Effects on Patient Care, and Provider and Patient Satisfaction. Blood 2014, 124: 4857. DOI: 10.1182/blood.v124.21.4857.4857.
- Myeloproliferative NeoplasmsWong EY, Rose MG. Myeloproliferative Neoplasms Chapter. In: Primary Care, eds. Rose MG, DeVita VT, Lawrence TS, Rosenberg S, Oeffinger KC, Schwenk TL, Wender RC. Lippincott Williams & Wilkins, 1st ed. 2013.
- Abstract 309: Induction of activation-induced cytidine deaminase (AID) by dendritic cells leads to genomic instability in human myelomaKoduru S, Wong E, Strowig T, Sundaram R, Zhang L, Strout M, Flavell R, Schatz D, Dhodapkar K, Dhodapkar M. Abstract 309: Induction of activation-induced cytidine deaminase (AID) by dendritic cells leads to genomic instability in human myeloma. Cancer Research 2012, 72: 309-309. DOI: 10.1158/1538-7445.am2012-309.
- Erythroid Expression of the Human α-Spectrin Gene Promoter Is Mediated by GATA-1- and NF-E2-binding Proteins*Boulanger L, Sabatino DE, Wong EY, Cline AP, Garrett LJ, Garbarz M, Dhermy D, Bodine DM, Gallagher PG. Erythroid Expression of the Human α-Spectrin Gene Promoter Is Mediated by GATA-1- and NF-E2-binding Proteins*. Journal Of Biological Chemistry 2002, 277: 41563-41570. PMID: 12196550, DOI: 10.1074/jbc.m208184200.